Stock Analysts’ Upgrades for January, 17th (BYG, FOUR, GPRK, GST, GTXI, HIIQ, HMHC, HNRG, HTGM, HTZ)

Stock Analysts’ upgrades for Wednesday, January 17th:

Big Yellow Group (LON:BYG) was upgraded by analysts at Berenberg Bank to a buy rating. Berenberg Bank currently has GBX 920 ($12.48) price target on the stock, up from their previous price target of GBX 820 ($11.12).

4imprint Group (LON:FOUR) was upgraded by analysts at Peel Hunt to an add rating. Peel Hunt currently has GBX 2,050 ($27.80) price target on the stock.

Geopark (NYSE:GPRK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $12.00 price target on the stock. According to Zacks, “GeoPark Ltd is an explorer, operator and consolidator of oil and gas. The company operates primarily in Chile, Colombia, Brazil and Argentina. GeoPark Ltd is based in Hamilton, Bermuda. “

Gastar Exploration (NYSEAMERICAN:GST) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.50 price target on the stock. According to Zacks, “Gastar Exploration Ltd is an exploration and production company focusing on developing primarily natural gas. Gastar Exploration Ltd is based in Houston, Texas. “

GTX (NASDAQ:GTXI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions. GTx’s lead candidate is enobosarm, a selective androgen receptor modulator, or SARM, targeted at the androgen receptor, or AR, in women with advanced breast cancer whose tumors express the androgen receptor and the estrogen receptor, or ER, and women with AR positive triple negative breast cancer. GTx is also evaluating enobosarm for the treatment of other serious medical conditions where building lean body mass is important. “

Health Insurance Innovations (NASDAQ:HIIQ) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “

Houghton Mifflin Harcourt (NASDAQ:HMHC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Houghton Mifflin Harcourt Company is a global provider of education solutions, delivering content, technology, services and media to students in over 150 countries worldwide. The Company delivers its offerings to both educational institutions and consumers. It provides kindergarten through twelfth grade, or K-12, educational content in the United States. The Company, through its subsidiary, provides print and electronic textbook curriculum, learning content, and assessment tools and services. Houghton Mifflin Harcourt Company is headquartered in Boston, Massachusetts. “

Hallador Energy (NASDAQ:HNRG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $7.75 target price on the stock. According to Zacks, “Hallador Energy Company, formerly known as Hallador Petroleum Company is engaged in the production of steam coal. The Company’s primary operating property is the Carlisle underground coal mine located in western Indiana. Hallador Energy Company is based in Denver, Colorado. “

HTG Molecular Diagnostics (NASDAQ:HTGM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $4.00 price target on the stock. According to Zacks, “HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona. “

Hertz Global (NYSE:HTZ) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Hertz Global Holdings, Inc. operates car rental business. The company’s product and services consists of Hertz Gold Plus Rewards, NeverLost(R), Carfirmations, Mobile Wi-Fi and unique vehicles offered through the Adrenaline, Dream, Green and Prestige Collections. It operates primarily in North America, Europe, Latin America, Asia, Australia, Africa, the Middle East and New Zealand. Hertz Global Holdings, Inc. is based in FL, United States. “

Independence Contract Drilling (NYSE:ICD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Independence Contract Drilling Inc. provides land drilling services for oil and natural gas producers primarily in the United States. The Company provides the US E&P industry a fleet of ShaleDriller (TM) rigs for drilling and development of shale and tight oil basins in North America. Independence Contract Drilling, Inc. is based in Houston, Texas. “

InterDigital (NASDAQ:IDCC) was upgraded by analysts at Zacks Investment Research from a sell rating to a strong-buy rating. Zacks Investment Research currently has $93.00 target price on the stock. According to Zacks, “InterDigital develops fundamental wireless technologies that are at the core of mobile devices, networks, and services worldwide. Since their founding in 1972, their engineers have designed and developed a wide range of innovations that are used in digital cellular and wireless products and networks, including 2G, 3G, 4G and IEEE 802-related products and networks. They solve many of the industry’s most critical and complex technical challenges, inventing solutions for more efficient broadband networks and a richer multimedia experience years ahead of market deployment. InterDigital has licenses and strategic relationships with many of the world’s leading wireless companies. “

Ingredion (NYSE:INGR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $152.00 target price on the stock. According to Zacks, “Ingredion Incorporated is an ingredients solutions provider specializing in nature-based sweeteners, starches and nutrition ingredients. The Company serves diverse sectors in food, beverage, brewing, pharmaceuticals and other industries. Its sweetener products include dextrose, glucose, polyols, HFCS and Maltodextrin. The Company’s nutrition solutions include prebiotic fibers, resistant starch, soluble fibers and Inulin fibers. Its starch-based products include both industrial and food-grade starches. Ingredion Incorporated, formerly known as Corn Products International, Inc., is headquartered in Chicago. “

Insmed (NASDAQ:INSM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $35.00 price target on the stock. According to Zacks, “Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company’s inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs. “

Spire Healthcare Group (LON:SPI) was upgraded by analysts at Jefferies Group LLC to a buy rating. Jefferies Group LLC currently has GBX 290 ($3.93) price target on the stock, up from their previous price target of GBX 259 ($3.51).

Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Vetr from a hold rating to a buy rating. The firm currently has $22.65 target price on the stock.

Receive News & Ratings for Big Yellow Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Big Yellow Group plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply